CLPT ClearPoint Neuro, Inc.

$14.05 -1.89%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

ClearPoint Neuro, Inc. (CLPT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $429 million. Shares last traded at $14.05, 53.2% below their 52-week high. Over the past year the stock is up 37.3%. Net profit margin is -81.8%, below the peer median of -9.3%. Revenue grew 17.8% year over year.

Market Cap

$429M

Shares Out

30.5M

EPS (TTM)

$-2.07

P/E Ratio

—

P/S Ratio

10.14

P/B Ratio

39.77

Dividend / Share

—

Dividend Yield

—

52-Week High

$30.00

52-Week Low

$8.34

Volume

26,037

Avg Vol (3m)

28,670.571

Performance

-11.77%

+6.93%

-1.85%

+52.39%

YTD

+0.00%

+37.34%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

41.38

SMA (50)

$15.64

SMA (200)

$13.42

Price vs SMA50

-10.17%

Price vs SMA200

+4.67%

ATR (14)

$1.01

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$42M

Net Income

$-35M

Gross Margin

62.6%

Operating Margin

-73.4%

Net Margin

-81.8%

Return on Equity

-320.8%

Return on Assets

-39.8%

Current Ratio

4.74

Debt / Equity

4.66

Revenue Growth (YoY)

+17.8%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.70	2026-08-03
Q1 2026	$-0.32	2026-05-13
FY 2025	$-0.90	2026-03-17
Q3 2025	$-0.63	2025-11-06
Q2 2026	$-0.42	2026-08-03
Q1 2026	$-0.22	2026-05-13

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

CLPT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

10.14 / 2.94 med

+245% premium

Net margin vs peers

-81.8% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.